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Abstract 
 
Strategies to prevent preterm birth in multifetal gestation remain a high-priority in the United States. 
In women with a history of spontaneous preterm birth (sPTB) and singleton gestation, transvaginal 
cervical length (TVCL) surveillance and subsequent treatment is associated with a reduction in 
spontaneous preterm birth, however, there is limited data on the role of TVCL surveillance in twin 
gestation. The goal of this study is to determine if an association exists between TVCL and 
spontaneous preterm birth in twin gestations. Additionally, our research will assess whether TVCL 
surveillance impacts the timing of antenatal corticosteroids (ACS), magnesium sulfate 
administration, and maternal and neonatal outcomes in multiple gestations. We performed a 
retrospective cohort study of women with twin gestations born at Methodist Women’s Hospital 
between January 1st, 2013 and April 30th, 2016. Patients having six or more TVCL measurements 
during their twin gestation were compared to those with less than six TVCL measurements. Women 
without TVCL measurement, monochorionic-monoamniotic twins, or monochorionic-diamniotic 
twins with twin-twin transfusion syndrome were excluded from statistical analysis.  We hypothesized 
that women who experience spontaneous preterm birth will demonstrate shorter TVCL 
measurements throughout their surveillance. We also hypothesized that those with more frequent 
TVCL surveillance would result in optimized timing of ACS within seven days of delivery, increased 
exposure to magnesium sulfate in those born before 32 0/7 weeks and improved neonatal and 
maternal outcomes. Our study found no association between TVCL frequency and spontaneous 
preterm birth, exposure to magnesium sulfate for neuroprotection, or maternal or neonatal outcomes. 
Twins whom delivered at <34 0/7 weeks were more likely to receive first course ACS (55% vs 31%, 
p=0.03) within 7 days of delivery in the <6 TVCL measurement surveillance group. It was concluded 
that TVCL surveillance is not beneficial more frequently than every 28 days and timing of ACS and 
magnesium sulfate administration for neuroprotection should not be based on TVCL measurements.  
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Introduction 
 
Prematurity is the leading cause of death in children under the age of five.1-3 While more 
than 60% of preterm birth occurs in Africa and South Asia; preterm birth remains a global 
problem.1 While preterm birth rates remain highest for low-income countries (11.8% of live 
births), high-income countries maintain a relatively high rate (9.3% of live births).1 The United 
States accounts for 42% of the estimated 1.2 million preterm births occurring in high-income 
countries.1 The rate of preterm birth continues to increase in the United States, and remains an 
economic burden and public health concern.3  
 While preterm birth may be indicated for maternal or fetal medical indications, the 
majority of preterm births are spontaneous.4 Spontaneous preterm birth includes all birth 
following preterm labor, preterm premature rupture of membranes, or cervical insufficiency.4 An 
intermixing of genetic, epigenetic, and environmental risk factors drives spontaneous preterm 
birth, and an identified cause remains unknown in more than 50% of cases.1 Behavioral risk 
factors for premature birth include low maternal pre-pregnancy weight, smoking, substance 
abuse, prior cervical surgery and short-interval pregnancy.4 Women with a prior preterm birth 
have a 1.5 fold increased risk of premature birth in a subsequent pregnancy.4 Vaginal bleeding, 
urinary or genital tract infections, and periodontal disease during pregnancy are also believed to 
increase risk; however, one of the strongest clinical risk factors for preterm birth is multifetal 
gestation.4 
Women with multiple gestations are six times more likely to give birth <37 0/7 weeks 
and thirteen times more likely to give birth before 32 0/7 weeks than women with singleton 
gestations.5 The mean gestational age for a twin to be born is preterm at 35.3 weeks.2 The twin 
birth rate in the United States rose 76% from 1980 to 2009, leading to a 40% increase in the 
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proportion of preterm births due to twin gestations.6 In addition, there is disproportionate 
morbidity and mortality associated with multiple gestations.6 Twins have a 4-fold higher 
mortality risk, with 50% of deaths occurring from the complications of prematurity. 6 Thus, the 
prevention and management of premature birth in multifetal gestation remains a high-priority 
when developing strategies to reduce morbidity and mortality related to preterm birth within the 
United States. 
Screening for preterm birth risk has traditionally included transvaginal cervical length  
(TVCL) surveillance. It is well-established that a shorter midtrimester TVCL increases the risk 
of premature birth in both singleton and multiple gestations.7,8 The Preterm Prediction Study 
(1996) found that a midtrimester TVCL less than or equal to 25mm was associated with a six 
fold increase in premature birth in singleton gestations and an eight fold increase in twin 
gestations.7 Cervical length surveillance has become an integral part of obstetric practice in the 
prevention of preterm birth and those identified by TVCL at risk for preterm birth in singleton 
gestation may benefit from an intervention such as cerclage or progesterone therapy.4  
In many institutions, TVCL surveillance has expanded to include twin gestations; 
however, there is no evidence to suggest cervical length surveillance and subsequent 
interventions (cerclage or progesterone treatment) decrease neonatal morbidity or mortality in 
twins.2 Secondary to this lack of evidence, The American College of Obstetricians and 
Gynecologists (ACOG) does not recommend the use of TVCL surveillance in asymptomatic 
women with multifetal gestations.2 Even with this recommendation, TVCL surveillance in 
multiple gestations remains widely used in clinical practice with the goal of identifying women 
who may benefit from closer monitoring and optimizing administration of antenatal 
corticosteroids (ACS).   
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The optimal frequency of cervical length surveillance in twin gestations remains 
unknown. Recent meta-analyses suggest that a transvaginal ultrasound during the second 
trimester is a powerful predictor of preterm birth in multiple gestation.9,10 Given that the timing 
of cervical shortening may occur anytime during the second trimester, serial monitoring of 
cervical length into early in the third trimester to improve detection rates and determine pattern 
of change or rate of cervical shortening has been suggested.11,12 In two studies, Melamed et al. 
found that the relative degree of shortening over time improved the prediction of preterm birth at 
<32 weeks in singleton and multiple gestations compared with a single measurement and 
classified four patterns of cervical lengths over time each with an independent risk for preterm 
birth.11,12 Notably, the optimal frequency of cervical length surveillance and how to best use the 
information obtained requires further research.  
Currently, there is no evidence for an effective intervention to prolong gestation in 
multiple gestation pregnancies with a short cervix.2 If gestation cannot be prolonged, the 
information may be used to help clinicians and families best prepare for a premature birth. This 
surveillance also may allow for appropriately timed administration of antenatal corticosteroids 1-
7 days before birth in twin pregnancies, which has been found to have a significant reduction in 
neonatal mortality, short-term respiratory morbidity, and severe neurological injury similar in 
magnitude to that observed in singletons.13,14 Studies have demonstrated that twin newborns 
delivering >7 days after their ACS treatment experienced significantly more respiratory disorders 
and were hospitalized longer than infants receiving steroids <7 days before birth if born at <34 
weeks.15 Thus, the timing of ACS relative to delivery in twin gestations remains a critical 
intervention to maximize neonatal outcomes.  
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Previous literature remains conflicted on the use of cervical length measurements for the 
appropriate timing of ACS administration in twins. Several studies have found cervical length ≤2 
cm and cervical change to be strong predictors of optimally timed ACS.16, 17 Marcellin et al. 
reported that routine monthly cervical length monitoring compared to targeted use in women 
with suspected preterm labor does not affect the rate of ACS administration <34 weeks.18 
Further, their findings suggested that in those born >34 weeks more individuals in the routine 
surveillance group received steroids, suggesting routine surveillance may lead to a greater 
amount of unnecessary ACS administration.18 Cervical length surveillance also has been 
suggested to help time administration of magnesium sulfate for neuroprotection when delivery is 
anticipated before 32 weeks gestation in twins.4 The effectiveness of this has yet to be studied. 
Further research is needed to determine the role and frequency of cervical length surveillance in 
the timing of ACS and magnesium sulfate.  
If TVCL is associated with improved timing of ACS administration, it is important to 
determine if TVCL surveillance and its subsequent clinical decision pathway are cost effective in 
the reduction of neonatal morbidity associated with respiratory distress syndrome. In singleton 
gestations, universal TVCL screening has been shown to be cost effective to identify those at risk 
for preterm delivery. In an analysis by Werner et al., for every 100,000 women with low-risk 
singleton gestations screened $12,119,947 could be saved, 423.9 quality adjusted life years could 
be gained, and 22 cases of neonatal death due to prematurity could be prevented.19 These results 
are largely due to the use of progesterone to prevent premature birth when a short cervix is 
identified. In twin gestations, no effective strategy has been proven to prevent preterm birth, thus 
it is important to determine if the potential benefit of improved neonatal respiratory and 
neurological morbidity gained from appropriately timed antenatal corticosteroids and magnesium 
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sulfate administration outweighs the cost associated with a TVCL screening strategy in twins. 
The financial costs must be considered for TVCL surveillance as part of the armamentarium of 
care when outcome data concerning morbidity and mortality are still being evaluated to 
determine best future practices concerning cervical length measurements in twin gestations. 
Preterm birth remains a leading cause of morbidity and mortality in the United States 
despite significant effort and research into its prevention. There are currently no interventions 
with significant evidence to prolong gestation in multiples, and TVCL surveillance is not 
recommended by the American College of Obstetrics and Gynecologists. Yet, TVCL is often 
used in multifetal gestations with varying frequency to help clinicians predict preterm birth and 
time interventions such as antenatal corticosteroid administration. The literature is inconclusive 
on whether TVCL improves this timing, and no literature exists on the economic impact of 
universal TVCL screening in twins. This study aims to add to the limited literature and help 
guide clinicians on best practice for their patients, including considerations of the financial 
impact of TVCL surveillance.  The purpose of this study is to (1) determine if there is an 
association between the frequency of cervical length surveillance and spontaneous preterm birth 
in twins; (2) determine if an association exists between the frequency of cervical length 
surveillance and the timing of ACS administration; (3) determine if an association exists between 
the frequency of cervical length surveillance and the timing of magnesium sulfate for 
neuroprotection; (4) determine if an association exists between the frequency of cervical length 
surveillance and composite maternal and neonatal morbidity; and (5) determine the economic 
impact of implementing standard TVCL surveillance in twin gestations.  
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Problem Statement 
Shortened cervical length measurements on TVCL has been associated with spontaneous preterm 
birth, yet there is limited data regarding the frequency of this surveillance in twin births and 
whether this surveillance affects interventions such as timing of antenatal corticosteroid 
administration within seven days of delivery.   
Research Question 1:  
Does an association exist between TVCL surveillance frequency and the rate of 
spontaneous preterm birth among twin gestations? 
Hypothesis 1: 
1. Women who receive six or more cervical lengths measurements are less likely to 
experience spontaneous preterm birth compared to women who receive less than 6 
cervical lengths measurements among twin gestations. 
Research Question 2: 
Does an association exist between TVCL surveillance frequency and the timing of 
antenatal corticosteroid administration among twin gestations delivering at ≤34 0/7 
weeks?  
Hypothesis 2: 
1. Women who receive ≥6 TVCL measurements are more likely to receive any (first 
course or rescue) antenatal corticosteroid administration within seven days of delivery 
among twin gestations delivering at ≤34 0/7 weeks compared to women who receive <6 
TVCL measurements. 
Research Question 3: 
Does an association exist between TVCL surveillance frequency and exposure to 
magnesium sulfate for neuroprotection in twins born ≤32 0/7 weeks? 
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Hypothesis 3: 
1. Women who receive ≥6 TVCL measurements are more likely to be exposed to 
magnesium sulfate for neuroprotection if born at ≤32 0/7 weeks compared to women who 
receive <6 TVCL measurements. 
Research Question 4:  
Does an association exist between TVCL surveillance frequency and composite maternal 
and neonatal morbidity among twin gestations? 
Hypothesis 4: 
1. Women who received ≥6 TVCL measurements are more likely to be associated with 
lower composite maternal (e.g. peripartum venous thromboembolism, pelvic abscess, 
sepsis, wound disruption, intensive care unit admission, blood transfusion, and 
readmission) and neonatal (e.g. umbilical artery pH <7.1, five minute APGAR <5, 
diagnosis of respiratory distress syndrome, bronchopulmonary dysplasia, retinopathy, 
periventricular leukomalacia, intraventricular hemorrhage grade 3 or 4, necrotizing 
enterocolitis, proven sepsis, stillbirth or death before discharge) morbidity among twin 
gestations compared to women who receive <6 TVCL measurements. 
Research Question 5:  
What is the economic impact of incorporating a universal TVCL surveillance strategy in 
twins and considering neonatal morbidity and mortality outcomes? 
Hypothesis 5:  
1. Implementing a universal TVCL surveillance strategy will be cost effective at reducing 
neonatal morbidity and mortality compared to no TVCL surveillance 
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Research Design and Methods 
 
A retrospective cohort study was chosen to include all twin pregnancies delivered at Methodist 
Women’s Hospital in Omaha, Nebraska between January 1st, 2013 and April 30th, 2016 using a 
pre-existing de-identified database, which was approved by the Methodist Women’s Hospital 
Research Ethics Board and waived by UNMC Ethics Board. Cases for the database were 
identified using ICD 9 discharged codes V27.2 (Outcome of delivery, twins, both live born) and 
V27.3 (Outcome of delivery, twins, one live born and one stillborn). Maternal and neonatal 
outcomes were individually extracted from medical records. A single research team member was 
responsible for performing all data abstraction and entry of identified cases to avoid 
interpersonal variation in data collection methods. A random sample of five patients every one 
hundred was chosen and reviewed for accuracy to ensure data quality. For this study, all twins 
within the database were screened for analysis. Women without TVCL measurement, 
monochorionic-monoamniotic twins, and monochorionic-diamniotic twins with a history of 
twin-twin transfusion syndrome were excluded. Those	  with	  ≥6 TVCL measurements were 
compared with those with <6 TVCL measurements. 
 Gestational age was determined by earliest ultrasound examination. All ultrasound 
reports throughout gestation were reviewed for TVCL measurements. The gestational age at 
TVCL measurement and TVCL measurement in millimeters was recorded.    
All sonographic examinations were performed by experienced sonographers and 
interpreted by a maternal-fetal medicine physician using a transvaginal approach. The 
measurement of TVCL was done using a set protocol as described by Iams et al.20 A transvaginal 
probe was placed into the anterior fornix of the vagina while the women’s bladder was empty. 
The appropriate sagittal view was identified, visualizing the full length of the endocervical canal 
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from the internal to the external cervical os while exerting as little pressure as possible on the 
cervix. Three measurements were taken and the shortest measurement was recorded. The 
presence of cervical funneling, either spontaneously or in response to fundal pressure, was also 
documented.    
 In order to evaluate charges associated with surveillance, the following information was 
obtained from the database for each patient: the number of TVCLs performed, inpatient hospital 
days for cervical shortening, outpatient administration of ACS following the diagnosis of 
cervical shortening, the cervical length at which these decisions occurred, and whether or not 
delivery occurred within seven days of ACS administration. Charges were obtained from 
Methodist Hospital System financial records. The total charge for each patient was calculated 
using the total number of TVCL performed, administration of outpatient ACS, and inpatient 
admission for ACS. The added charge of implementing a standardized TVCL surveillance 
protocol into Methodist Health system was determined.  
Chorionicity was confirmed by placental pathology following delivery. Baseline maternal 
characteristics collected included: age, parity, race, insurance status at delivery, height and 
weight at diagnosis of pregnancy, mode of conception, smoking status, chronic conditions, and 
history of preterm birth, diabetes, or hypertensive disorders in pregnancy. The use of antenatal 
corticosteroids and magnesium sulfate for neuroprotection during pregnancy was abstracted from 
medical records. The gestational age at which these were completed was recorded. Additional 
maternal outcomes included hospital days greater than five, number of days of bed rest, use of 
tocolytics, development of gestational hypertension, preeclampsia, gestational diabetes, preterm 
premature rupture of the membranes, indication for delivery, mode of delivery, and postpartum 
hemorrhage. A set maternal morbidity composite was recorded to include any of the following: 
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peripartum venous thromboembolism, pelvic abscess, sepsis, wound disruption, ICU admission, 
blood transfusion, and readmission. Additional neonatal outcomes included were gestational age 
at delivery, birthweight Twin A, birthweight Twin B, weight discordance, and admission and 
length of stay (days) in the neonatal intensive care unit. A predefined neonatal composite of 
adverse outcomes included: umbilical artery pH <7.1, five minute APGAR <5, diagnosis of 
respiratory distress syndrome, bronchopulmonary dysplasia, retinopathy, periventricular 
leukomalacia, intraventricular hemorrhage grade 3 or 4, necrotizing enterocolitis, proven sepsis, 
stillbirth or death before discharge.  
Statistical analysis was performed using Statistical Package for the Social Science 
Version 24 (SPSS) by IBM Analytics. Continuous variables were compared using a Student’s T 
test. Categorical variables were explored using Chi-squared tests or Fisher’s exact tests where 
appropriate based on cell size. The threshold for significance for all tests will be set at P < 0.05. 
A power analysis using Gpower computer program indicated that a total sample size of 128 
would be needed to detect medium effects (d=.5) with 80% power using a t test between means 
with an alpha at .05. 
Results 
Characteristics of the Study Population 
A total of 424 women with twin pregnancies were identified during the study period, of whom 
359 (84.7%) were eligible for the study. 47 (11%) had no TVCL performed at Methodist 
Women’s Hospital Perinatal Center, 4 (1%) were monochorionic monoamniotic twin 
pregnancies, and 14 (3.3%) were monochromic diamniotic twin pregnancies diagnosed with 
twin-twin transfusion syndrome (Figure 1).  
Figure 1. Study Population Selection 
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The characteristics of these excluded groups did not differ from our included population. 
Demographic characteristics of our population are included in Table 1.  
Women in the ≥6 TVCL measurement group received TVCL screening significantly 
more frequently (8.5 ± 2.9 times during pregnancy vs. 3.8 ± 1.1 times during pregnancy, 
p=<0.001). The mean gestational age at delivery did not differ between the two groups (34.9 ± 
3.6 weeks, ≥6 vs 35.3 ± 2.4 weeks; p=0.36). Those that received ≥6 TVCL measurements were 
more likely to have a monochorionic-diamniotic pregnancy (19.2% vs 10.9%, p=0.03), had a 
greater likelihood of cerclage placement (8.9% vs 1.3%, p=0.002), and were more likely to be 
exposed to tocolytics (35.5% vs 17.3%, p=<0.001). Additionally, while those in the ≥6 TVCL 
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measurement group had statistically significantly lower BMI (26.5 ± 6.4 vs 28.0 ± 6.6, p=0.03) 
this is unlikely clinically significant. 
Table 1. Maternal Population Demographics 
 
Spontaneous Preterm Birth Rates 
Previous work from our cohort presented at the 38th Annual Pregnancy meeting in Dallas, Texas 
on February 2nd, 2018, demonstrated significantly shorter TVCL after 23 weeks gestation in 
those women who ultimately experienced spontaneous preterm birth at < 32 0/7 weeks, 32 0/7 to 
33 6/7 weeks, and at 34 0/7 to 36 6/7 weeks (Figure A1). However, higher TVCL frequency did 
not improve the rate of spontaneous preterm birth. As shown in Table B1, no association existed 
between the frequency of TVCL surveillance and the rate of spontaneous preterm birth at <32 






n= 156 n= 203
Gestational age at delivery, weeks ± SD 34.9 ± 3.6 35.3  ± 2.4 0.36
Age (years ± SD) 31.3 ± 4.8 31.5 ± 4.8 0.7
Caucasian (%) 146 (93.6%) 192 (94.6%) 0.69
Medicaid, n (%) 10 (6.4%) 15 (7.4%) 0.72
Nulliparity, n (%) 57 (36.5%) 69 (34%) 0.62
BMI, kg/m2 ± SD 28.0 ± 6.6 26.5 ± 6.4 0.03
Conception via reproductive technology, n (%) 79 (50.6%) 82 (40.4%) 0.06
Monochorionic-Diamniotic, n (%) 17 (10.9%) 39 (19.2%) 0.03
Chronic hypertension, n (%) 15 (9.6%) 11 (5.4%) 0.13
Diabetes (any), n (%) 18 (11.5%) 27 (13.3%) 0.62
Tobacco Use, n (%) 8 (5.1%) 9 (4.4%) 0.76
History of Cervical Surgery, n (%) 4 (2.6%) 6 (3.0%) 0.82
History of Preterm Birth, n (%) 6 (3.8%) 12 (5.9%) 0.37
Average Number of TVCL during Pregnancy, 
mean ± SD (min, max)
3.8 ± 1.1 (1,5) 8.5 ± 2.9 (6, 22) <.001
Cerclage, n (%) 2 (1.3%) 18 (8.9%) 0.002
Preterm Labor Symptoms, n (%) 57 (36.5%) 94 (46.3%) 0.08
Polyhydramnios, n (%) 37 (23.7%) 62 (30.5%) 0.15
Exposure to Tocolytics, n (%) 27 (17.3%) 72 (35.5%) <.001
Cesarean Delivery, n (%) 102 (65.4%) 137 (67.5%) 0.68
Maternal Characteristics
p value
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Timing of Antenatal Corticosteroids 
Women with higher TVCL surveillance frequency whom delivered at >37 0/7 weeks were more 
likely to be exposed to antenatal corticosteroids during pregnancy (11/56 (19.6%)) than women 
with less TVCL surveillance frequency whom delivered at >37 0/7 weeks (3/56 (5.4%), p 
value=0.02) (Table B2). There is no significant difference in ACS exposure between groups 
among those who delivered at <37 0/7 weeks, <34 0/7 weeks, or <32 0/7 weeks. Of twins whom 
delivered at <34 0/7 weeks, the mean days between first course ACS exposure (21.78 ± 16.3 vs 
9.62 ± 11.6, p=0.03) or any ACS exposure (14.97 ± 14.97 vs 7.61 ± 9.41, p=0.01) and delivery 
was significantly higher in the >6 TVCL measurement surveillance group. Twins whom 
delivered at <34 0/7 weeks were more likely to receive first course ACS (55% vs 31%, p=0.03) 
or any ACS exposure (47.5% vs. 23.8%, p=0.02) within 7 days of delivery in the <6 TVCL 
measurement surveillance group. ACS were given more frequently for an indication of cervical 
length less than 25 mm in the >6 TVCL measurement frequency group than the <6 TVCL 
measurement frequency group. Other ACS indications included preterm labor, PPROM, IUGR, 
and preeclampsia.  
Magnesium Sulfate Exposure for Neuroprotection  
 
There is no evidence to suggest that the frequency of TVCL surveillance is associated with 
exposure to magnesium sulfate in twins born at <32 0/7 weeks. In our study population of those 
born at <32 0/7 weeks, exposure to magnesium sulfate for neuroprotection trended higher but not 
statistically significant in the ≥6 TVCL (68% vs 54%, p=0.34)(Table B3).  
Composite Maternal and Neonatal Morbidity 
 
Maternal morbidity and neonatal morbidity were analyzed using composites. Composite 
maternal morbidity included peripartum venothromboembolism, pelvic abscess, sepsis, wound 
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disruption, ICU admissions, blood transfusion, and readmission to the hospital. Among TVCL 
frequency groups there is no evidence to suggest a difference in composite maternal morbidity 
(7.7% vs 7.4%, p=0.91) (Table 5). Composite neonatal morbidity included umbilical artery pH 
<7.1, five minute APGAR <5, diagnosis of respiratory distress syndrome, bronchopulmonary 
dysplasia, retinopathy, periventricular leukomalacia, intraventricular hemorrhage grade 3 or 4, 
necrotizing enterocolitis, proven sepsis, and stillbirth or death before discharge in either twin. 
Among TVCL frequency groups there is no evidence to suggest a difference in composite 
neonatal morbidity (24.4% vs 24.6%, p=0.95) (Table B4.). 
TVCL Screening for Reassurance  
The negative predictive value of TVCL screening was also determined in our study population. 
Table 2 displays the negative predictive value of spontaneous delivery following a negative 
TVCL screening at varying gestational ages. A negative TVCL screen was defined as a TVCL 
measurement >25 mm. Regardless of gestational age at screening, no women experienced a 
spontaneous delivery within 7 days following a negative screening. The negative predictive 
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Table 2. TVCL Screening, Negative Predictive Value  
 
 
The Cost of TVCL Screening 
While a negative TVCL measurement provides reassurance against sPTB up to 28 days after 
screening, more frequent TVCL surveillance did not improve the timing of ACS or magnesium 
sulfate administration in our study population making it unlikely to be cost effective in the 
reduction of neonatal morbidity and mortality. Thus, a cost-effective analysis was not performed. 
In its place, we decided to investigate the total charges associated with TVCL surveillance and 
its potential economic impact on the organization and its patients.  
In order to investigate the total charges associated with TVCL screening, it was first necessary to 
understand the various clinical decision pathways our perinatalogists take when a woman screens 
positive for a short cervix, as defined by a TVCL measurement <25 mm in agreement with 
previous studies (Figure 2). In our study population 27.0% of women with twin gestations 
experienced a short cervix during pregnancy (Table C1). The pathway of intervention appears to 




Age of TVCL 
Screening
n >25 mm 
TVCL in 
GA period
7 days 14 days 21 days 28 days
24 weeks 0/7 - 
25 weeks 6/7
236 1 0.992 0.979 0.979
26 weeks 0/7 - 
27 weeks 6/7
224 1 1 0.996 0.978
28 weeks 0/7 - 
29 weeks 6/7
156 1 0.994 0.987 0.981
30 weeks 0/7 - 
31 weeks 6/7
67 1 0.97 0.925 0.866
32 weeks 0/7 - 
33 weeks 6/7
14 1 0.929 0.714 0.643
Negative Predictive Value (NPV) of TVCL Screening
NPV of Spontaneous Delivery within x days of >25 mm 
TVCL Screening
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Figure 2: Management Tree for TVCL Measurements in Pregnancy 
 
Following the finding of a short cervix, 47% (n=46/97) of women were admitted to the 
antepartum unit for ACS administration and observation with an average TVCL measurement of 
12.65 ± 5.72 mm and at an average gestational age of 27.19 ± 2.33 weeks. Nearly half of these 
women (n=22/46, 47.8%) were symptomatic on admission. Of those admitted, 42 (91.3%) 
received a course of ACS at some point in the admission, but only 6 (13%)were within the 
recommended 1 to 7 days of delivery. Delivery occurred an average of 42.47 ± 26.93 days after 
ACS completion. Although every patient was admitted under 72-hour observation, 26 (56.5%) 
transferred to a full admission. On average, a patient admission lasted 6.67 ± 6.53 days compared 
to the expected 48-72 hours. Four women were readmitted later in pregnancy under the same 
indication. Spontaneous preterm birth at <34 0/7 weeks was experienced by 47.8%, with 8 
(36.4%) of these deliveries occurring during an admission for a short cervix.  
Women who received outpatient ACS for the discovery of a short cervix appeared to 
have a longer cervix (16.21 ± 3.88 mm) and were less likely to be symptomatic (0%), but tended 
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to be of similar gestational age (27.88 ± 2.48 weeks) compared to those who were admitted. No 
women in the outpatient ACS group received steroids within the recommend 1-7 days of 
delivery, although 50% (n=9/18) experienced sPTB at <34 0/7 weeks.  
 A cerclage appeared to be the intervention of choice among women with a short cervix 
identified in the second trimester. This group had an average gestational age of 21.48 ± 2.0 
weeks at the time of positive screening. Additionally, TVCL measurement appeared to be shorter 
(10.98 ± 8.0 mm) compared to either the admitted or outpatient ACS groups. Spontaneous 
preterm birth at <34 0/7 weeks was experienced in 23.5% (n=4/17) women with cerclage. 
 A final clinical decision pathway included no immediate intervention at the time of 
identifying a short cervix. These positive screens appeared to occur at slightly later gestational 
ages (29.29 ± 1.86 weeks) and have considerably longer TVCL measurements (20.97 ± 2.96 
mm). Only 7.7% (n=2/26) of women receiving no intervention for a short cervix had a sPTB at 
<34 0/7 weeks.  
 Our study population of 379 patients had a total of 2,311 TVCL performed during a 40-
month time period. Hospital charges were obtained from financial charge sheets and medication 
charges were obtained through outpatient pharmacy services. The total charge associated with 
TVCL measurements during this time period was estimated at $1,585,346, an average of 
$418,297 per 100 patients (Table C2). Observation admission charges were estimated at 
$19,743, or $5,209 per 100 patients. The charges for transfers to full admissions and a 
corresponding discharge summary estimated $21,892, or $5,776 per 100 patients. These hospital 
charges may be considered basic minimum charges of a stay as other interventions that may have 
occurred during hospitalization were not included. Total charges for outpatient ACS amounted to 
an estimated $8,064, or $2,127 per 100 patients. This includes medication and injection for a full 
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course of ACS (two doses 24 hours apart). The estimated charge for a cerclage suture placement 
and subsequent removal under anesthesia, required by one-third of our patients, was $8,948, or 
$2,361 per 100 patients. Overall, the current TVCL surveillance in the twin population 
approximates $433,770 per 100 patients. 
Discussion/Recommendations 
In our comparison of TVCL surveillance frequencies, we found that: 1) increased TVCL 
surveillance frequency did not improve sPTB rates at < 32 0/7 weeks, <34 0/7 weeks, or <37 0/7 
weeks, 2) women who received ≥6 cervical lengths were significantly less likely to receive any 
(first course or rescue) antenatal corticosteroid administration within seven days if delivery 
occurred at ≤34 0/7 weeks; 3) no association of TVCL surveillance frequency with magnesium 
sulfate exposure or composite neonatal or maternal morbidity, 4) the negative predictive value of 
a TVCL screen over 2.5cm is >98% up to 28 days between 24 0/7 weeks and 29 6/7 weeks 
gestation; and 5) TVCL surveillance is unlikely cost effective in the management of sPTB in 
twin gestations with total charges amounting to $433,770 per 100 patients with twin gestation at 
our institution.   
 Our findings support previous studies conclusions that TVCL is a strong predictor of 
sPTB in women with twin gestations. While we found that women ≥6 TVCL (approximately 
every 2-weeks in the second trimester) compared to women who had <6 TVCL (approximately 
every 4-weeks in the second trimester) during their twin pregnancy did not improve neonatal and 
maternal outcomes in our study population; thus, there was no advantage to performing more 
frequent surveillance. Furthermore, the negative predictive value of a TVCL >2.5cm was similar 
at 28 days compared to 14 days. While this may prove reassuring to providers and patients, it 
remains unclear whether the cost of this surveillance is warranted given it did not improve timing 
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of any intervention that may improve perinatal outcomes. Future research to compare every four-
week TVCL measurements during pregnancy to no TVCL measurements during pregnancy may 
further elucidate the optimal frequency of surveillance, if any exists.  
  Previous studies on the use of TVCL measurements for the appropriate timing of ACS 
administration in twins have been conflicting. Several studies have found cervical length ≤2 cm 
and cervical change to be strong predictors of optimally timed ACS.19, 20 Other studies have 
reported routine monthly cervical length monitoring, compared to targeted use in women with 
suspected preterm labor, did not affect the rate of ACS administration in those delivering at <34 
weeks. 16 In fact, in those born >34 weeks, more patients in the routine surveillance group 
received steroids, suggesting high frequency surveillance leads to a greater amount of 
unnecessary ACS administration. 16 Optimizing timing of ACS remains important minimizing 
morbidities associated with prematurity, thus it is crucial to determine methods, if any, clinicians 
can use to identify patients who will benefit from ACS.  
In a retrospective comparison between a practice with standardized TVCL and fetal 
fibronectin surveillance and one without this routine surveillance, Lifshitz et al. found improved 
optimal ACS exposure in the standardized surveillance cohort.21 In contrast, our findings suggest 
that women receiving more frequent TVCL measurements were significantly less likely to 
appropriately receive first course or any ACS (first course or rescue) within the recommended 1 
to 7-day window. In fact, the mean days between ACS course completion and delivery was twice 
that in the ≥ 6 TVCL surveillance group compared to the <6 TVCL surveillance group and led to 
a greater amount of unnecessary ACS administration in those born at >34 0/7 weeks.  
Individuals in either frequency group who screened positive for a short cervix were found 
to receive frequent and often unnecessary intervention in our study population. In addition to the 
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cost of ACS, these patients were frequently admitted to the hospital without delivery. The 
negative financial and emotional impact of prolonged hospitalization is not to be underestimated. 
At the discovery of a short cervix, patients are counseled that they will be admitted for a short 
observation to receive an ACS course; however, our findings suggest that patients often end up 
hospitalized considerably longer than 72 hours as providers discover alternative indications that 
would likely have gone unnoticed in an outpatient setting.  
Prolonged hospitalization has financial impact beyond that of medically-related charges 
including the indirect financial impact through the loss of a woman’s contribution to the 
workforce or by pulling other family members out of work to help care her and her additional 
children. While difficult to quantify, it is worth noting that the estimated cost of an obstetric 
intervention such as bedrest that includes lost wages and productivity costs approximately $250 
to billions of dollars per year.22 
It is also important to consider that the ≥6 TVCL measurement group had a significantly 
higher number of cerclage placements during the study period, despite the lack of evidence for 
their efficacy in multiple gestations. The more screening measurements taken, the higher 
likelihood a positive screen occurs prompting an unnecessary intervention. While providers and 
patients may be tempted to do something for a positive screen, rather than solely observing, this 
adds medical cost with no evidence-based benefit. A routine TVCL measurement may spiral into 
an invasive surgical intervention merely to give a patient the sense that their physician has “done 
something” to help. 
Our study was the first to assess the effectiveness of TVCL surveillance in twins with 
regard to timing of magnesium sulfate for neuroprotection when delivery is anticipated <32 0/7 
weeks. We found that more frequent surveillance did not improve the rate of appropriately timed 
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administration of magnesium sulfate, thus a shortened TVCL should not be a contributing factor 
in the decision to administer magnesium sulfate in patients at risk of delivery at <32 weeks.  
One factor for TVCL surveillance in twin gestations despite the recommendations of 
ACOG is patient/provider reassurance of negative screening. The negative predictive value of 
TVCL measurements in multiple gestations was found to be >98% up to 28 days following a 
negative screen in those between 24 0/7 weeks and 29 6/7 weeks gestation. This information 
allows for further discussion into the frequency at which TVCL should be performed in twin 
gestations. If a patient has a negative screen at <29 6/7 weeks there is no clinical indication to re-
screen during the next 28 days as her chance of sPTB is very low. If TVCL screening is to be 
performed during twin pregnancy, this provides further evidence for every 4-week TVCL 
screening compared to every 2-week TVCL screening in the second trimester. This level of 
reassurance may be especially beneficial for women living at great distance from a NICU able to 
care for a preterm infant, as is common in our Nebraskan patient population. Further research is 
necessary to determine if TVCL screening in the rural population has an impact on the location 
of delivery and availability of resources to care for a preterm infant.  
With a lack of benefit in women who screen positive for a short cervix, the cost 
associated with TVCL surveillance should be considered. The ≥6 TVCL surveillance group 
underwent an average of 8.5 ± 2.9 TVCL at a charge of $686 per TVCL measurement, leading to 
an estimated charge of $5,861 ± $2019 per twin pregnancy. The <6 TVCL surveillance group 
received an average of 3.8 ± 1.1 TVCL measurements during pregnancy, an estimated charge of 
$2,607 ± $755 per twin pregnancy. As there is no added benefit to every two-week TVCL 
surveillance compared to every four-week surveillance, this modification to surveillance would 
result in a 55.5% decrease in cost. Future study to compare every four-week TVCL 
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measurements during pregnancy to no TVCL measurements during pregnancy may further 
address this question. If it is determined that every four-week TVCL measurements during 
pregnancy provides no added benefit the potential cost savings and avoidance of unnecessary 
hospitalizations approximates $433,770 per 100 patients with twin gestation.  
We recognize limitations in our study. TVCL measurement frequency is at the discretion 
of the individual provider. While ≥6 and <6 TVCL measurement frequencies corresponded to 
approximately every two-week and every four-week surveillance in the second trimester, 
respectively, these measurements may not have always been at evenly spaced intervals. 
Providers often increased the frequency of surveillance at the discovery of a short cervix. Our 
study was hindered by our access to financial data. We were unable to analyze the full estimated 
cost of a prolonged hospitalization due to non-transparency in billing costs and limited 
authorized access to financial information on patients.  
Strengths of our study should also be noted. All TVCL measurements and interventions 
studied were provided at a single institution. Additionally, our study added to the limited 
literature TVCL surveillance and associated timing of antenatal corticosteroids. We anticipate 
our study will serve to spark discussion among perinatalogists, obstetricians, and the public 
health community about best practice for twin gestations with the goal of maximizing perinatal 
outcomes and minimizing unnecessary intervention and added cost.  
Conclusion 
TVCL surveillance in multiple gestations remains widely used in clinical practice with 
the goal of identifying women who may benefit from closer monitoring and optimizing 
administration of antenatal corticosteroids (ACS); however, our study calls these goals into 
question. Higher frequency TVCL surveillance did not improve the optimization of ACS, 
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magnesium sulfate administration, or composite neonatal or maternal morbidity. We recommend 
the clinical decision to administer an ACS course not be based on a TVCL measurement <25 
mm. Until an effective intervention for the prevention of sPTB in multiple gestations is 
determined, TVCL surveillance does not appear to improve perinatal outcomes related to 
prematurity in multiple gestations. A TVCL screen measuring >25 mm, however, did provide a 
high level of reassurance against sPTB within 28 days. Cost considerations of universal TVCL 
surveillance to provide this reassurance must be balanced against the limits of public health 
resources and may be a key cost saving measure for hospitals performing the surveillance. 
Further research is needed to identify select groups of patients, such as those from rural areas 
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Gesta5onal	  Age	  (weeks)	  
Mean	  Transvaginal	  Cervical	  Length	  by	  Gesta5onal	  Age	  Spontaneous	  Term	  
(≥37	  0/7)	  vs	  Preterm	  (<32,	  32	  0/7	  -­‐	  33	  6/7,	  34	  0/7	  -­‐	  36	  6/7)	  weeks	  	  
>37	  0/7	  weeks	  (Total	  TVCL	  =	  622)	   34	  0/7	  to	  36	  6/7	  weeks	  (Total	  TVCL	  =	  756)	  
32	  0/7	  to	  33	  6/7	  weeks	  (Total	  TVCL	  =	  325)	   <32	  0/7	  weeks	  (Total	  TVCL	  =	  156)	  
























n= 156 n= 203
Spontaneous Preterm Birth at <37 weeks 0 days, n (%) 49 (31.4%) 77 (37.9%) 0.20
Spontaneous Preterm Birth at <34 weeks 0 days, n (%) 21 (13.5%) 32 (15.8%) 0.54
Spontaneous Preterm Birth at <32 weeks 0 days, n (%) 13 (8.3%) 14 (6.9%) 0.61






n= 156 n= 203
Overall ACS Exposure, n (%) 48 (30.8%) 81 (39.9%) 0.07
Delivery >37 0/7 weeks, n (%) 3/56 (5.4%) 11/56 (19.6%) 0.02
Delivery <32 0/7 weeks, n (%) 22/24 (91.7%) 18/19 (94.7%) 0.59
Delivery <34 0/7 weeks, n (%) 34/38 (89.5%) 36/42 (85.7%) 0.74
Delivery <37 0/7 weeks, n (%) 45/100 (45%) 70/147 (47.6%) 0.69
First Course ACS to delivery if <34 0/7 weeks, 
mean days ± SD 9.62 ±  11.6 21.78 ±  16.3 0.03
Any ACS (1st course or rescue) to delivery if <34 
0/7 weeks, mean days ± SD 7.61 ±  9.14 14.97 ±  14.97 0.01
Any ACS (1st course or rescue) >7 days of delivery 
if <34 0/7 weeks 15/38 (39.5%) 20/42 (47.6%) 0.46
Any ACS (1st course or rescue) ≤7 days of delivery 
if <34 0/7 weeks 21/38 (55.3%) 13/42 (31%) 0.03
RDS in either twin with sPTB <34 0/7 weeks, n (%) 6/21 (28.6%) 4/32 (12.5%) 0.17
Steroids Given due to TVCL <25 mm 6/38 (15.8%) 23/42 (54.8%) <.001
Rescue ACS course ≤7 days of delivery if < 34 0/7 
weeks 2/38 (5.3%) 6/42 (14.3%) 0.27
Antenatal Corticosteroid (ACS) Exposure
p value
First ACS course ≤7 days of delivery if < 34 0/7 
weeks 19/38 (47.5%) 10/42 (23.8%) 0.02
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 12 (7.7%) 15 (7.4%) 0.91 
Composite Neonatal Morbidity
2




























MgSO4 Given if delivery at <32 weeks 0/7 days 13/24 (54.2%) 13/19 (68.4%) 0.34
Magnesium Sulfate (MgSO4) Exposure for Neuroprotection
1 Peripartum VTE, Pelvic Abscess, Sepsis, Wound Disruption, ICU Admit, Blood 
Transfusion, Re-admission, n (%) 
2 UA pH < 7.1, 5 min. APGAR < 5, RDS, BPD, Retinopathy, PVL, IVH 3 or 4, NEC, 
Proven Sepsis, Stillbirth or Death Before Discharge, n (%) 
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Appendix C 
 












Number of TVCL <25 mm, n (%) 97/359 (27.0%)
Number of Women Admitted for Positive Screen, n (%) 46/97 (47.4%)
CL at admission, mm ± SD (min, max) 12.65 ± 5.72 (0, 23)
GA at occurrence of admisison, weeks ± SD (min, max) 27.19 ± 2.33 (23.57, 31.43)
Received ACS during hospitalization, n (%) 42 (91.3%)
Inpatient Steriods Given within 7 days of delivery, n (%) 6 (13.0%)
Mean days between ACS and Delivery, days ± SD (min, max) 42.47 ± 26.93 (1.0, 91.0)
Average days of Admission, days ± SD (min, max) 6.67 ± 6.53 (1, 28)
Transfer to Full Admission, n (%) 26/46 (56.5%)
Symptomatic on Admission, n (%) 22 (47.8%)
Readmission for Short Cervix, n (%) 4 (8.7%)
sPTB at <34 weeks 0 days, n (%) 22 (47.8%)
sPTB at <34 weeks 0 days with delivery during admission, n (%) 8/22 (36.3%)
sPTB at <34 weeks 0 days with symptoms on admit, n (%) 10/22 (45.5%)
Number of Women Receiving Outpatient ACS for Positive Screen, n (%) 18/97 (18.6%)
GA at steriod completion, weeks ± SD (min, max) 27.88 ± 2.48  (24, 31.14)
CL at decision for steriods, mm ± SD (min, max) 16.21 ± 3.88 (7.7, 20.7)
Symptomatic at presentation, n (%) 0 (0%)
Outpatient Steriods Given within 7 days of delivery, n (%) 0 (0%)
Mean days between ACS and Delivery, days ± SD (min, max) 41.39 ± 25.13 (11.0, 91.0)
sPTB at <34 weeks 0 days 9 (50%)
Number of Women Receiving Cerclage for Positive Screen, n (%) 17/97 (17.5%)
GA at cerclage, weeks ± SD (min, max) 21.48 ± 2.0 (17.43, 24.14)
CL at cerclage, mm ± SD (min, max) 10.98 ± 8.0 (0, 28.5)
sPTB at <34 weeks 0 days, n (%) 4 (23.5%)
No Intervention with Positive Screen, n (%) 26/97 (26.8%)
GA at shortest TVCL, weeks ± SD (min, max) 29.29 ± 1.86 (25.71, 32.86)
Average shortest TVCL, mm ± SD (min, max) 20.97 ± 2.96 (14.10, 25.0)
sPTB at <34 weeks 0 days 2 (7.7%)
Intervention for a Positive Screen (TVCL < 25 mm) 
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High Risk Hospital Observation $429
Hospital Discharge Management >30 minutes $290
Transfer to Full Hospital Admission $552
Outpatient ACS
Medication Cost $40
Staff Injection Fee $184
Cerclage 
Cerclage Suture Placement $407
Removal of Cerclage Suture Under Anesthesia $358
TVCL Screening
Facility TVCL Screening Cost $404
Professional Fee $282
Cost of Intervention
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Service Learning/Capstone Experience Reflection  
Describe the experience with the placement site. 
-What did you learn about the organization? 
-What was different than what you expected when you started the project? 
 
My experience at my placement site was incredibly positive. I developed strong 
relationships with not only my preceptor, but also the other perinatalogists in the office. These 
relationships will last into my future career as an obstetrician gynecologist and public health 
professional providing me mentorship and community. In addition to providing feedback and 
suggestions for my project, these individuals were kind enough to be my sounding board as I 
debated residency programs and went on interviews. The staff were always available to help me 
trouble shoot when I ran into computer access issues or needed to figure out who I needed to 
contact in various Methodist financial departments. I have the utmost respect for all physicians, 
sonographers, and staff at this office.   
I was able to consistently observe the coordination it takes to provide the highest quality 
of care for patients with complicated pregnancies. Receptionists, nurses, sonographers, 
geneticists, and a team of physicians all play essential roles in patient care and patient education. 
I was able to gain valuable knowledge and skills through each of these different professions. As 
a future physician I will make sure to recognize and respect each and every one of my staff 
members that help me care for patients. The people who work behind the scenes often go 
unnoticed, particularly when it comes to research. Physicians would not be able to produce the 
research that they do without their staff. It takes significant time and effort to gain funding, write 
an IRB, gather data, perform an analysis, and write/publish a professional paper. The work 
behind research cannot be underestimated, but I also think something I learned throughout this 
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process is that quality research is possible. The process intimidated me, but Methodist staff really 
taught me it was possible even without all the tools and resources some academic intuitions have.  
As I had already been researching for Methodist at the start of my project there were not 
many things that were different than I expected. I did expect the financial information I was 
seeking to be more attainable than it was. It took many phone calls with many different 
individuals to gain access to prices on specific ICD codes and without a code I was not able to 
gain any information. I was surprised by physicians’ lack of knowledge of the charges for the 
interventions and medications they prescribe their patients. I was not aware of the disconnect 
between the perinatal office and the Methodist staff that do the billing prior to the start of my 
capstone.  
Describe how SL/CE activities were performed: what, where, when, with whom, how long, etc. 
-What resources, relationships, and skills permitted these activities to occur? 
All of my activities revolved around my creation of a database for the Methodist perinatal 
system and research activities based on this database. I created a database of all twins born at 
Methodist Women’s Hospital from January 1st, 2013 to April 30th, 2016. This database contains 
an immense amount of variables for current and future research projects. My capstone project 
was only a small part of the variables that I added. As a part of my service learning hours, I 
added several variables based on requests from the perinatalogists for future research projects. 
All of my data collection was performed in rotating offices at the perinatology office based on 
whichever physician was off that day. I performed all data collection alone; however, I would 
often discuss the proper way to define the variables with physicians and staff in the office when I 
ran into difficulty.  
Data analysis as well as the production of abstracts, manuscripts, and my capstone paper 
was performed between Methodist and my home laptop (via a deidentified version). I would 
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often sit in my preceptor’s office during his clinic hours and between patients we would discuss 
the variables we wanted to analyze and the best way to perform the analysis. While he was off 
seeing patients, I would perform this analysis and report to him when he returned. There was also 
a significant amount of back and forth emails of drafted versions of the abstracts we submitted to 
the annual pregnancy meeting as well as the poster creation for this meeting.  
Additionally as a part of my service learning hours, I had the honor of submitting and 
being accepted to present a poster at the annual pregnancy meeting in Dallas, Texas. This 
meeting occurred from January 29th- February 3rd, 2018. This was an incredible learning 
experience for me as I was able to listen to oral presentations of the latest breaking research in 
my future field. Dr. Dahlke was kind enough to introduce me to key individuals in the field and 
help me network for my future career. This was my first poster presentation and it was an 
excellent experience to be able to go through the process from start to finish. I learned how 
rewarding and sometimes challenging it is to describe your research to other professionals. I had 
a significant number of people come ask me questions, even several European physicians. It was 
very valuable to experience the various ways one can share research with the community in order 
to change practice patterns.  
As I was nearing the end of my time at Methodist, I spent time cleaning up the database 
in order to pass it on to the next person that will continue to expand this database and the 
research. I also helped Methodist reach out into the medical and public health schools at UNMC 
to find potential candidates to “replace me” as a research assistant. I held casual meetings with 
several students to discuss my research and explain the roles, responsibilities, and benefits of 
working with the perinatal center. It was fun to be able to share my research with my peers and 
encourage those in the earlier stages of school to get involved in research.  
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 I am very thankful for the resources and people that allowed this project to be possible. 
The Methodist perinatal office really opened up its arms to me and created opportunities for me 
to access any resources I needed for this research. The most valuable resource to this project was 
my preceptor and the other perinatalogists in the office. They truly had an open door policy with 
me. I was able to stroll into their office at any time and they were more than willing to discuss 
research strategy or to teach me various statistical skills. By allowing me to be apart of their 
conversations, I gained an enormous amount of medical knowledge that will benefit me as I enter 
my residency in obstetrics and gynecology. I truly feel leaps and bounds above my peers. The 
perinatalogists consistently provided me with research to read up on relating to my topic or 
relating to an interesting patient we had been discussing.  
 The skills I needed for my capstone project included skills in defining variables, proper 
and efficient data collection, and statistical analysis. These are all skills I gained during my 
public health curriculum and it was rewarding to be able to put that knowledge to use. While 
learning in a class setting is beneficial, I truly believe that you will never fully acquire a skill into 
you apply it to a project such as this one. I am very grateful to this requirement to graduate with 
my masters.  
Describe the product(s) (training manual, presentation, brochure, policy statement, database, 
etc.) that were outcomes of the Service Learning component. 
-If a presentation was developed, for whom was the presentation developed? 
-If a database was developed, what was the sustainability plan to continue tracking the 
data? 
 
 The outcome of my service learning component was a database on all twins (N=424) 
born between January 1st, 2013 and April 30th, 2016 at Methodist Women’s Hospital as well as 
the presentation of one abstract at the annual pregnancy meeting in Dallas, TX and the 
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submission of two additional abstracts to the ACOG annual meeting in Austin, TX to be 
presented at the end of April following the conclusion of my capstone.  
 A poster presentation was developed for the 38th Annual Pregnancy meeting. I was able 
to share my research project with many professionals in the field of perinatology. The two 
posters to be presented at the National ACOG meeting will be shared with members of the entire 
obstetrics and gynecology community. 
 There is a sustainability plan for the database. I have several medical students in the class 
below me that plan to continue to add to the database and hopefully get it up to the current time. 
I am planning to meet with these individuals in April/May after they have been added to IRB to 
teach them my method of gathering data and where to locate all the variables within the 
Methodist electronic medical record. I will also make sure the database is easy to read and be 
used by the perinatalogists in the office so they may continue research projects I began for them.  
Related to your Service Learning activities, what do you think were your greatest 
contributions/accomplishments? What strengths did you bring into the project? 
 
 I think my greatest contribution to the organization was the database itself. They had 
previously had an individual who was gathering data on twins on simple paper forms. I started 
where this individual left off, however I created an electronic and more readily useable version 
of the data going forward. This database is now available for any Methodist perinatalogist to use 
at their convenience and desire. I also think that I added to the organization by presenting 
research at a national conference. Research output is a measure of the strength of an institution 
and I was able to add to Methodist’s strength in this area but representing the organization on a 
national level.  
 I believe the greatest strengths I brought to the project were my motivation and work 
ethic. I was able to be a driving force for research within the clinic. The physicians previously 
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had the desire to produce research, but did not have the time with their busy clinic schedules. I 
was able to provide my time and skills to make their research desires become a reality. Gathering 
data was a time intensive process and took significant motivation to accomplish, as it is often 
hard to picture the end product. I am proud of the time I put in and the outcome of the project. 
What were the greatest challenges of your Service Learning/Capstone Experience? 
-How did you address and overcome those challenges? 
 
 The greatest challenge of my project was gathering financial information on various 
interventions. In order to gather the financial information I had to reach individuals outside of the 
Methodist clinic, but still within the Methodist system. Without specific ICD-10 codes I was not 
able to gain charge amounts for interventions. The individuals in the billing office were slightly 
weary of why I needed the numbers, and I would need to know the exact information I needed 
prior to communicating with them. There were also various ways of billing for the 
hospitalizations I was trying to record and it became difficult to estimate the exact charges for 
each hospitalization. In order to overcome this challenge, I ended up modifying the charge 
numbers I gathered. I used only the charge numbers for hospital observation admissions, 
transfers to full admissions, and discharge paperwork. The charges for interventions during 
hospitalization were challenging and too variable to make accurate estimates. With the help of 
my committee chair, I was able to use an outside source to gain information about the cost of 
antenatal corticosteroids and the cost of their administration.  
 Another challenge I faced during the project was balancing time between medical school 
and my master’s project. It was harder than anticipated to balance spending time on my project 
while I was traveling on medical residency interviews throughout October-January. To overcome 
this challenge, I would set out specific days and times when I knew I could be at the Methodist 
office or go to a coffee shop to truly focus on the project. I had to use my time management 
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skills as well as be within constant communication with my preceptor. It was also challenging to 
be out of the country on rotation for the months of February and March. Working on a project 
remotely was not without challenges. I am grateful to my committee for being understanding 
during this difficult time as I complete my project.   
How have your views of public health practice been impacted by your SL/CE? 
 
Prior to the start of this project I was intimated by performing public health research and 
did not fully understand how it worked. My view of this has drastically changed. Research is 
innovative and stimulating. While difficult and often not glamorous, it is definitely achievable 
with the right resources. The end product makes the process worth it. It was extremely fun when 
my group reached the point of data analysis, as I was able to see that my research had the 
potential to positively change practice patterns within my institution and on a larger scale. I 
believe my views of public health practice have changed from this process because I have a 
greater respect and appreciation of each and every step of the process. The amount of work that 
goes into taking an idea and making it a reality in the public health realm cannot be 
underestimated.   
How did your public health education prepare you to address any ethical or other issues you 
encountered during your SL/CE? 
 
While no ethical issues arose during my project, my public health education helped me to 
prevent potential ethical issues. The main potential issue was the keeping patient information 
confidential and in the proper locations to ensure its safety. I knew what information I was and 
was not allowed to access and who I was able to share it with. I learned how to properly 
deidentify data so that I would be able to work on my project remotely. Additionally, my public 
health education helped me to do quality statistical analysis to help ensure the integrity of the 
information I distributed to the greater public health community. 
